What’s Driving Hartalega’s Share Price Recovery Above RM1?

1. Sector Is Entering a Recovery Phase (Finally)
After years of oversupply and price compression, analysts now see FY2026 as the start of a more sustained glove sector rebound, supported by:

a. Improving demand and easing excess capacity in the global glove market.
b. Stabilising average selling prices (ASPs) after years of decline.
c. US demand strengthening, benefiting Malaysia’s major glove exporters.

These trends benefit the “Big Four” — including Hartalega — which are showing gradual improvements as utilisation rates normalise and inventories stabilise.

2. Restocking Cycle Is Kicking In
Analysts note that glove buyers (especially in the US) have started replenishing depleted inventories, lifting sales volume for Malaysian producers:

a. Restocking and improved utilisation have supported sequential earnings improvements sector-wide.
b. Higher demand visibility in 2026 is contributing to renewed investor confidence.

This demand uptick is one of the strongest medium-term catalysts for Hartalega.

3. Hartalega’s Own Earnings Have Improved
While still pressured, Hartalega’s financials have shown meaningful stabilisation:

a. Net profit rose 112% in its Sept 2025 quarter compared to the previous year, signalling operational recovery.
b. Its latest financials (Q3 FY2026) show improved margins and stronger net income vs. earlier quarters.

Even though numbers are still below pre-pandemic levels, the direction is clearly positive — a key sentiment driver for investors.

4. Competition From China Is Easing Slightly
A major drag previously was the flood of cheap Chinese gloves entering non-US markets. But now:

a. Chinese players are experiencing higher tariffs in the US (up to 80%), pushing buyers back toward Malaysian producers.
b. Some Chinese manufacturers are shifting production to Southeast Asia, but Malaysian producers remain competitive due to better automation, energy efficiency and labour practices.

This has helped Hartalega secure 53% of sales to the US in its recent quarter.

5. Cost Optimisation + Automation Upgrades
Hartalega has been aggressively cutting costs and boosting productivity:

a. Workforce reduced by up to 15% through efficiency improvements.
b. Ongoing multi-year automation upgrades to improve yield and reduce reliance on labour.

These structural improvements enhance margins, making the company more resilient.

6. Overall Market Sentiment Has Turned Less Negative
While still cautious, analysts now see:

a. Limited downside at current valuations.
b. Some target price upgrades (e.g., MIDF and Kenanga saw improving profitability trends earlier).

This shift in sentiment reduces selling pressure and supports price recovery toward and above RM1.

So… Is HARTALEGA Below NTA + Net Cash a Buy?

If you’re a value investor:

HARTA fits the classic deep-value profile:
✅ below NTA
✅ strong cash position
✅ recovery cycle emerging
✅ cost optimisation improving earnings
This makes it reasonably attractive, especially for long-term, cyclical investors.

If you’re a growth/income investor:

Be cautious.
❌Sector margins remain thin.
❌ASP recovery is still slow.
❌Competition from China is persistent.
❌Dividends are small for now.

✅ Conclusion:
Yes, buying HARTA below NTA with RM1B cash can be considered a value-buy
The upside depends heavily on how quickly oversupply clears and ASPs recover in 2026–2027.